The Pro product, which received FDA 510(k) clearance in 2017, is intended to be used in a clinical setting for tracking upper-extremity rehab in adult patients. "Importantly, the collaboration will enable access to technology for patients to train intensively in the vital window of brain plasticity while extending training opportunities post-stroke."įounded in 2012, the Swiss startup offers products like MindMotion Go and MindMotion Pro. John Krakauer, chief medical director for MindMaze, said in a statement. This partnership allows us to work with a world-class partner to develop evidence-driven implementation models to scale our technologies in a seamless and cost-effective way," Dr. "MindMaze develops digital neurotherapeutic solutions designed to elevate outcome expectations today and to accelerate the future of cognitive recovery and care. The health system and the startup will use data generated from the program to determine its effectiveness and its potential to scale. Under the partnership, Mount Sinai will use MindMaze's software and hardware to provide an outpatient rehab program followed by home-based digital care, assessment and monitoring. MindMaze, which makes game-like rehabilitation tools for neurological conditions and injuries, announced a partnership with New York-based Mount Sinai Health System to offer a digital therapeutic program for stroke and concussion patients.
0 kommentar(er)
